Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Context Therapeutics (CNTX)

Context Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNTX
DateTimeSourceHeadlineSymbolCompany
16/05/202421:01Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CNTXContext Therapeutics Inc
10/05/202421:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CNTXContext Therapeutics Inc
08/05/202421:06GlobeNewswire Inc.Context Therapeutics Reports First Quarter 2024 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
08/05/202421:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CNTXContext Therapeutics Inc
02/05/202412:31GlobeNewswire Inc.Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76NASDAQ:CNTXContext Therapeutics Inc
02/05/202412:30GlobeNewswire Inc.Context Therapeutics Announces $100 Million Private PlacementNASDAQ:CNTXContext Therapeutics Inc
01/04/202412:30GlobeNewswire Inc.Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive CancersNASDAQ:CNTXContext Therapeutics Inc
21/03/202411:43GlobeNewswire Inc.Context Therapeutics Reports Full Year 2023 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
06/03/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
07/02/202421:24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CNTXContext Therapeutics Inc
09/11/202321:15GlobeNewswire Inc.Context Therapeutics Reports Third Quarter 2023 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
09/11/202321:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CNTXContext Therapeutics Inc
31/10/202313:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
31/10/202313:00GlobeNewswire Inc.Context Therapeutics Announces Preclinical Data Demonstrating Differentiated and Active Profile of its Claudin 6-Targeted Bispecific Antibody CTIM-76NASDAQ:CNTXContext Therapeutics Inc
27/09/202314:00GlobeNewswire Inc.Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:CNTXContext Therapeutics Inc
09/08/202321:10GlobeNewswire Inc.Context Therapeutics Reports Second Quarter 2023 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
09/08/202321:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CNTXContext Therapeutics Inc
07/08/202313:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
01/08/202312:30GlobeNewswire Inc.Context Therapeutics to Participate in Two August 2023 Investor ConferencesNASDAQ:CNTXContext Therapeutics Inc
20/06/202313:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTXContext Therapeutics Inc
31/05/202321:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTXContext Therapeutics Inc
10/05/202321:39GlobeNewswire Inc.Context Therapeutics Reports First Quarter 2023 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
03/04/202312:30GlobeNewswire Inc.Context Therapeutics to Participate in Two April 2023 Investor ConferencesNASDAQ:CNTXContext Therapeutics Inc
27/03/202321:04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CNTXContext Therapeutics Inc
22/03/202321:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTXContext Therapeutics Inc
22/03/202321:08GlobeNewswire Inc.Context Therapeutics Reports Full Year 2022 Financial Results and Recent Pipeline UpdatesNASDAQ:CNTXContext Therapeutics Inc
15/03/202311:30GlobeNewswire Inc.Context Therapeutics Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2023NASDAQ:CNTXContext Therapeutics Inc
14/02/202322:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTXContext Therapeutics Inc
14/02/202322:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTXContext Therapeutics Inc
14/02/202322:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTXContext Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CNTX

Your Recent History

Delayed Upgrade Clock